![Bo Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bo Chen
Vorstandsvorsitzender bei
KEYMED BIOSCIENCES INC.
Profil
Bo Chen is the founder of Wuhan Huaxin Kangyuan Biopharma Co. Ltd., founded in 2011.
Dr. Chen is currently Chairman & Chief Executive Officer at Keymed Biosciences, Inc. since 2018.
Formerly, Dr. Chen was Executive Director at Shanghai Junshi Biosciences Co., Ltd. from 2016 to 2018.
Dr. Chen completed an undergraduate degree at Wuhan University in 1996 and a doctorate at Albert Einstein College of Medicine, Inc. in 2003.
Aktive Positionen von Bo Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| KEYMED BIOSCIENCES INC. | Vorstandsvorsitzender | 23.04.2018 |
Ehemalige bekannte Positionen von Bo Chen
| Unternehmen | Position | Ende |
|---|---|---|
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Vorstandsvorsitzender | 24.06.2018 |
Wuhan Huaxin Kangyuan Biopharma Co. Ltd. | Gründer | - |
Ausbildung von Bo Chen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
89
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Wuhan University
 Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Junshi Biosciences Co., Ltd.
 Shanghai Junshi Biosciences Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures monoclonal antibody drugs | Health Technology |
Keymed Biosciences, Inc.
 Keymed Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the treatment of asthma, chronic obstructive pulmonary and other respiratory diseases | Health Technology |
Wuhan Huaxin Kangyuan Biopharma Co. Ltd. |
